Harry Hill
BSc, MSc, PhD (91Ö±²¥)
Population Health, School of Medicine and Population Health
Senior Research Fellow
+44 114 215 9130
Full contact details
Population Health, School of Medicine and Population Health
Regent Court (ScHARR)
30 Regent Street
91Ö±²¥
S1 4DA
- Profile
-
I am a Senior Health Economist specialising in decision modelling and economic evaluation. I joined the School of Medicine and Population Health in October 2017 as a Research Fellow in Health Economics. I work within the Policy Research Unit in Economic Methods of Evaluation in Health and Care Interventions (EEPRU).
Following the completion of my PhD in health economics at the University of 91Ö±²¥ in 2012, I worked as a health economist at both the University of Newcastle and the University of Manchester Division of Dentistry.
My work focuses on developing decision models in the areas of breast cancer screening and kidney failure. Notably, my research on breast cancer screening has played a pivotal role in influencing policy discussions between the National Screening Committee and the Department of Health and Social Care regarding the potential future reorganisation of the England Breast Cancer Screening Programme.
Currently, I serve as the Principal Investigator on an EEPRU project that assesses the health-economic impact of incorporating artificial intelligence for breast cancer detection within the Breast Cancer Screening Programme. I also work in clinical trials and often collaborate with 91Ö±²¥ Clinical Trials Research Unit. Recently completed and ongoing trials:
- Intensive therapy for moderate established rheumatoid arthritis (TITRATE trial, completed 2021),
- Robot-assisted radical cystectomy vs open radical cystectomy for patients with bladder cancer (iROC trial, completed 2023)
- Pre-implantation trial of histopathology in renal transplant allografts (PITHIA trial, completed 2024).
- Delivering effective non-invasive ventilation in motor neuron disease using intensive remote support (DENIM trial, started 2024)
- Early parenteral nutrition vs standard nutritional care following emergency laparotomy. (TONIC trial, started 2024)
- Research interests
-
- Decision modelling for health economic evaluations
- Trials-based health economic evaluations
- Applied microeconometrics, particularly quasi-experimental research
- Incorporating equity concerns in cost-effectiveness analyses
- Publications
-
Journal articles
- . BMC Proceedings, 18(S19), 22.
- . Health technology assessment (Winchester, England), 28(73), 1-230.
- . JAMA network open, 7(9), e2431715.
- . npj Digital Medicine.
- . British Journal of Cancer.
- . Kidney International Reports.
- . JAMA Network Open, 6(6), e2317255-e2317255.
- . BMJ Open, 12(6).
- . BMC Health Services Research, 21.
- . Programme Grants for Applied Research, 9(8).
- . Journal of Medical Ethics, 47(12).
- Exploring older Swiss people's preferred dental services for when they become dependent. Swiss Dental Journal, 130(11), 876-884.
- Exploring older Swiss people's preferred dental services for when they become dependent. Swiss Dental Journal, 130(11), 876-884.
- . Seminars in Arthritis and Rheumatism, 50(5), 1182-1190.
- . Community Dentistry and Oral Epidemiology.
- . Value in Health.
- . Value in Health, 23(3), 397-405.
- . Health Services and Delivery Research, 8(6).
- . Health Services and Delivery Research, 6(8).
- . BMC Health Services Research, 17(1).
- . Community Dentistry and Oral Epidemiology, 45(4), 310-316.
- . Community dental health, 34(2).
- . Journal of Public Health Dentistry, 77(4), 334-343.
- . PharmacoEconomics, 34(12), 1277-1297.
- . Journal of the American Geriatrics Society, 64(11), 2368-2373.
- . Health Services and Delivery Research, 4(22).
- . Value in Health, 18(7), A512-A513.
- . Journal of Healthcare Leadership, 2015(7), 13-20.
- . Future Hosp J, 2(1), 38-42.
- . Future Hospital Journal, 2(1), 38-42.
- . British Dental Journal, 217(9), E17-E17.
- . Emergency Medicine Journal, 31(10), 853-860.
- . Age and Ageing, 43(4), 559-562.
Reports
- Health related quality of life in economic evaluations in dementia: state of play and reflections
- Estimating the cost-effectiveness of risk stratified breast cancer screening
- Scoping, assessing feasibility, preliminary research and prioritising projects for the outcome measurement and valuation
- A literature review of methods to measure and value benefits in cost-effectiveness analyses of interventions for patients with either a short life expectancy or receiving palliative care’
- Final report for the technology evaluation of ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections.
- Summary report of the Health and Labour Outcomes (HaLO) Tool
- A review of the methods used to generate utility values in NICE technology appraisals for paediatrics
- Health for Wealth: Building a Healthier Northern Powerhouse for UK Productivity
- A feasibility study for building a health and work model. Report prepared for Public Health England
- Key issues and evidence sources in id885.
- An evaluation of an eReferral Management & Triage System for Minor Oral Surgery referrals from primary care dentists
- Teaching interests
-
I am an active supervisor and am interested in supervising research students in the areas of decision modelling for health economic evaluations and cost-effectiveness in clinical trials.
I supervise two PhD students: Asghar Meerza and George Tarun.
I teach on the module "Valuing the Benefits of Health Care" in the MSc Health Economics and Decision Modelling (HEDM) course. I also provide dissertation supervision to HEDM students.
- Professional activities and memberships
-
I am a member of the Yorkshire and North East Regional Advisory Committee for the NIHR Research for Patient Benefit Programme.
I serve as an advocate for neurodivergent individuals within the faculty which includes persons with conditions such as dyslexia, dyspraxia, autism spectrum disorder, attention deficit hyperactivity disorder, and other developmental or learning disorders. If you are a staff member or student who identifies as being neurodivergent, and have encountered workplace stress or challenges related to your condition, you can share your concerns with me anonymously. I will do my utmost to support and help resolve your issue.
I chair the Health Economics and Econometrics development group within the Division of Population Health.